Header Logo

Connection

TIMOTHY PALZKILL to Protein Binding

Back to Details
This is a "connection" page, showing publications TIMOTHY PALZKILL has written about Protein Binding.
TIMOTHY PALZKILL
Connection Strength
2.086
Protein Binding
  1. Deep Sequencing of a Systematic Peptide Library Reveals Conformationally-Constrained Protein Interface Peptides that Disrupt a Protein-Protein Interaction. Chembiochem. 2022 02 04; 23(3):e202100504.
    View in: PubMed
    Score: 0.143
  2. KPC-2 ?-lactamase enables carbapenem antibiotic resistance through fast deacylation of the covalent intermediate. J Biol Chem. 2021 Jan-Jun; 296:100155.
    View in: PubMed
    Score: 0.133
  3. Development and Evaluation of a Novel Protein-Based Assay for Specific Detection of KPC ?-Lactamases from Klebsiella pneumoniae Clinical Isolates. mSphere. 2020 01 08; 5(1).
    View in: PubMed
    Score: 0.125
  4. Systematic substitutions at BLIP position 50 result in changes in binding specificity for class A ?-lactamases. BMC Biochem. 2017 03 06; 18(1):2.
    View in: PubMed
    Score: 0.103
  5. BLIP-II Employs Differential Hotspot Residues To Bind Structurally Similar Staphylococcus aureus PBP2a and Class A ?-Lactamases. Biochemistry. 2017 02 28; 56(8):1075-1084.
    View in: PubMed
    Score: 0.102
  6. Identification and Characterization of Single-Chain Antibodies that Specifically Bind GI Noroviruses. PLoS One. 2017; 12(1):e0170162.
    View in: PubMed
    Score: 0.102
  7. Engineering Specificity from Broad to Narrow: Design of a ?-Lactamase Inhibitory Protein (BLIP) Variant That Exclusively Binds and Detects KPC ?-Lactamase. ACS Infect Dis. 2016 12 09; 2(12):969-979.
    View in: PubMed
    Score: 0.100
  8. Role of ?-lactamase residues in a common interface for binding the structurally unrelated inhibitory proteins BLIP and BLIP-II. Protein Sci. 2014 Sep; 23(9):1235-46.
    View in: PubMed
    Score: 0.085
  9. Identification of human single-chain antibodies with broad reactivity for noroviruses. Protein Eng Des Sel. 2014 Oct; 27(10):339-49.
    View in: PubMed
    Score: 0.085
  10. Identification of the ?-lactamase inhibitor protein-II (BLIP-II) interface residues essential for binding affinity and specificity for class A ?-lactamases. J Biol Chem. 2013 Jun 14; 288(24):17156-66.
    View in: PubMed
    Score: 0.079
  11. Identification and characterization of a peptide affinity reagent for detection of noroviruses in clinical samples. J Clin Microbiol. 2013 Jun; 51(6):1803-8.
    View in: PubMed
    Score: 0.078
  12. Metallo-?-lactamase structure and function. Ann N Y Acad Sci. 2013 Jan; 1277:91-104.
    View in: PubMed
    Score: 0.076
  13. Mutagenesis of zinc ligand residue Cys221 reveals plasticity in the IMP-1 metallo-?-lactamase active site. Antimicrob Agents Chemother. 2012 Nov; 56(11):5667-77.
    View in: PubMed
    Score: 0.075
  14. Use of periplasmic target protein capture for phage display engineering of tight-binding protein-protein interactions. Protein Eng Des Sel. 2011 Nov; 24(11):819-28.
    View in: PubMed
    Score: 0.070
  15. Identification of a ?-lactamase inhibitory protein variant that is a potent inhibitor of Staphylococcus PC1 ?-lactamase. J Mol Biol. 2011 Mar 11; 406(5):730-44.
    View in: PubMed
    Score: 0.067
  16. Identification and characterization of beta-lactamase inhibitor protein-II (BLIP-II) interactions with beta-lactamases using phage display. Protein Eng Des Sel. 2010 Jun; 23(6):469-78.
    View in: PubMed
    Score: 0.063
  17. Fine mapping of the sequence requirements for binding of beta-lactamase inhibitory protein (BLIP) to TEM-1 beta-lactamase using a genetic screen for BLIP function. J Mol Biol. 2009 Jun 05; 389(2):401-12.
    View in: PubMed
    Score: 0.060
  18. A high-throughput percentage-of-binding strategy to measure binding energies in DNA-protein interactions: application to genome-scale site discovery. Nucleic Acids Res. 2008 Sep; 36(15):4863-71.
    View in: PubMed
    Score: 0.057
  19. Dissecting the protein-protein interface between beta-lactamase inhibitory protein and class A beta-lactamases. J Biol Chem. 2004 Oct 08; 279(41):42860-6.
    View in: PubMed
    Score: 0.043
  20. Determinants of binding affinity and specificity for the interaction of TEM-1 and SME-1 beta-lactamase with beta-lactamase inhibitory protein. J Biol Chem. 2003 Nov 14; 278(46):45706-12.
    View in: PubMed
    Score: 0.040
  21. Binding properties of a peptide derived from beta-lactamase inhibitory protein. Antimicrob Agents Chemother. 2001 Dec; 45(12):3279-86.
    View in: PubMed
    Score: 0.036
  22. Protein minimization by random fragmentation and selection. Protein Eng. 2001 Jul; 14(7):487-92.
    View in: PubMed
    Score: 0.035
  23. The vimentin rod domain blocks P-selectin-P-selectin glycoprotein ligand 1 interactions to attenuate leukocyte adhesion to inflamed endothelium. PLoS One. 2020; 15(10):e0240164.
    View in: PubMed
    Score: 0.033
  24. DIRAS3 (ARHI) Blocks RAS/MAPK Signaling by Binding Directly to RAS and Disrupting RAS Clusters. Cell Rep. 2019 12 10; 29(11):3448-3459.e6.
    View in: PubMed
    Score: 0.031
  25. Structural, Biochemical, and In Vivo Characterization of MtrR-Mediated Resistance to Innate Antimicrobials by the Human Pathogen Neisseria gonorrhoeae. J Bacteriol. 2019 10 15; 201(20).
    View in: PubMed
    Score: 0.031
  26. Identification of residues in beta-lactamase critical for binding beta-lactamase inhibitory protein. J Biol Chem. 1999 Mar 12; 274(11):6963-71.
    View in: PubMed
    Score: 0.030
  27. Contributions of aspartate 49 and phenylalanine 142 residues of a tight binding inhibitory protein of beta-lactamases. J Biol Chem. 1999 Jan 22; 274(4):2394-400.
    View in: PubMed
    Score: 0.029
  28. Mapping protein-ligand interactions using whole genome phage display libraries. Gene. 1998 Oct 09; 221(1):79-83.
    View in: PubMed
    Score: 0.029
  29. Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death. Cancer Cell. 2015 Aug 10; 28(2):240-52.
    View in: PubMed
    Score: 0.023
  30. Probing the sites of interactions of rotaviral proteins involved in replication. J Virol. 2014 Nov; 88(21):12866-81.
    View in: PubMed
    Score: 0.022
  31. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1. Mol Endocrinol. 2011 Dec; 25(12):2041-53.
    View in: PubMed
    Score: 0.018
  32. Co-crystal structures of PKG I? (92-227) with cGMP and cAMP reveal the molecular details of cyclic-nucleotide binding. PLoS One. 2011 Apr 19; 6(4):e18413.
    View in: PubMed
    Score: 0.017
  33. The binary protein interactome of Treponema pallidum--the syphilis spirochete. PLoS One. 2008 May 28; 3(5):e2292.
    View in: PubMed
    Score: 0.014
  34. A novel Treponema pallidum antigen, TP0136, is an outer membrane protein that binds human fibronectin. Infect Immun. 2008 May; 76(5):1848-57.
    View in: PubMed
    Score: 0.014
  35. The protein network of bacterial motility. Mol Syst Biol. 2007; 3:128.
    View in: PubMed
    Score: 0.013
  36. Thermodynamic investigation of the role of contact residues of beta-lactamase-inhibitory protein for binding to TEM-1 beta-lactamase. J Biol Chem. 2007 Jun 15; 282(24):17676-84.
    View in: PubMed
    Score: 0.013
  37. Using peptide arrays to define nuclear carrier binding sites on nucleoporins. Methods. 2006 Aug; 39(4):329-41.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.